BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38406539)

  • 1. CD117 expression predicted FLT3 mutation in T-cell acute lymphoblastic leukemia.
    Wang H; Ni R; Wang A; Liu B
    EJHaem; 2024 Feb; 5(1):294-295. PubMed ID: 38406539
    [No Abstract]   [Full Text] [Related]  

  • 2. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
    Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
    Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutations.
    Zaremba CM; Oliver D; Cavalier M; Fuda F; Karandikar NJ; Chen W
    Ann Diagn Pathol; 2012 Jan; 16(1):16-20. PubMed ID: 22050963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.
    Paietta E; Ferrando AA; Neuberg D; Bennett JM; Racevskis J; Lazarus H; Dewald G; Rowe JM; Wiernik PH; Tallman MS; Look AT
    Blood; 2004 Jul; 104(2):558-60. PubMed ID: 15044257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.
    Shen Z; Chu XL; Wang RX; Li JL; Liu MY; Xie YY; Wang C; Han R; Yu JQ; Wang J; Tao T; Shen HJ; Chen SN; Wu DP; Qiu QC; Liu SB; Xue SL
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e259-e269. PubMed ID: 32173273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of FLT3-ITD in Tunisian childhood acute lymphoblastic leukemia.
    Frikha R; Abdellaoui N; Kassar O; Rebai T
    Afr Health Sci; 2022 Jun; 22(2):318-322. PubMed ID: 36407352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia.
    Sharawat SK; Gupta R; Raina V; Kumar L; Sharma A; Iqbal S; Bakhshi R; Vishnubhatla S; Bakhshi S
    Cytometry B Clin Cytom; 2013; 84(6):390-7. PubMed ID: 23740774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of FLT3 gene and FLT3/ITD mutation by polymerase chain reaction-single-strand conformation polymorphism in patients with acute lymphoblastic leukemia.
    Xu B; Li L; Tang JH; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1207-10. PubMed ID: 16234090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
    Aoyama K; Yamasaki Y; Mouri F; Maehiro Y; Takaki Y; Oya S; Nakamura T; Morishige S; Yamaguchi M; Nagafuji K
    Rinsho Ketsueki; 2022; 63(7):764-769. PubMed ID: 35922945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of FLT3 mutations in acute leukemia patients in Pakistan.
    Ishfaq M; Malik A; Faiz M; Sheikh I; Asif M; Khan MN; Qureshi MS; Zahid S; Manan A; Arooj M; Qazi MH; Chaudhary A; Alqahtani MH; Rasool M
    Asian Pac J Cancer Prev; 2012; 13(9):4581-5. PubMed ID: 23167384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
    Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
    PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias.
    Vela-Ojeda J; Cardenas PV; Garcia-Ruiz Esparza MA; Montiel Cervantes LA; Chavez JG; Caballero AH; Majluf-Cruz A; Vega-López A; Reyes-Maldonado E
    Arch Med Res; 2021 Feb; 52(2):217-223. PubMed ID: 33109387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23).
    Yamamoto K; Yakushijin K; Mizutani Y; Okuni-Watanabe M; Goto H; Higashime A; Miyata Y; Kitao A; Matsumoto H; Saegusa J; Matsuoka H; Minami H
    Cancer Genet; 2021 Jun; 254-255():92-97. PubMed ID: 33647817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.
    Chillón MC; Gómez-Casares MT; López-Jorge CE; Rodriguez-Medina C; Molines A; Sarasquete ME; Alcoceba M; Miguel JD; Bueno C; Montes R; Ramos F; Rodríguez JN; Giraldo P; Ramírez M; García-Delgado R; Fuster JL; González-Díaz M; Menendez P
    Leukemia; 2012 Nov; 26(11):2360-6. PubMed ID: 22705992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FLT3 mutation in patients with acute lymphoblastic leukemia and its clinical significance].
    Zhao X; Tang KJ; Tian Z; Chen LP; Mi YC; Wang JX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):522-6. PubMed ID: 19968062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
    Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
    Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia.
    Zhang Y; Zhang Y; Wang F; Wang M; Liu H; Chen X; Cao P; Ma X; Teng W; Zhang X; Liu H
    Cancer Gene Ther; 2020 Feb; 27(1-2):81-88. PubMed ID: 31285539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations.
    Jin A; Feng J; Wei G; Wu W; Yang L; Xu H; Zhang Y; Cui J; Chang AH; Hu Y; Huang H
    Bone Marrow Transplant; 2020 Apr; 55(4):717-721. PubMed ID: 32005917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.